Font size
- 1 2 3 + Font size

click to adjust

Page tools
Search
. Advanced search
Product Search
Information on veterinary pharmaceutical products:
For more search options

Corporate News

6. May 2008

Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe

Berlin, May 6, 2008 – Bayer Schering Pharma’s new low-dose oral contraceptive YAZ® has been approved in the EU.YAZ® will be the first oral contraceptive on the European market containing the unique... more

25. April 2008

“2007 was Bayer’s most successful year to date”

Previous year’s record levels and earnings targets exceeded / Dividend to be raised 35 percent to EUR 1.35 / Good start to fiscal 2008 / Bayer Climate Program being implemented and expanded more

24. April 2008

Bayer off to an excellent start in 2008

Sales up 2.4 percent to EUR 8,536 million / EBITDA before special items up 9.8 percent to EUR 2,185 million / EBIT before special items up 8.9 percent to EUR 1,497 million / Full-year guidance for... more

21. April 2008

Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®

Leverkusen, April 21, 2008 – Bayer confirmed that Bayer Schering Pharma AG and Bayer HealthCare Pharmaceuticals Inc. filed a patent infringement lawsuit in U.S. Federal Court in the Southern District... more

17. April 2008

Bayer donates €250,000 for patients with hemophilia and provides nearly 1 million international units of Kogenate®

World Hemophilia Day on April 17th more

2. April 2008

Bayer HealthCare Affiliate MEDRAD Announces Completion of Subsequent Offering Period for Shares of Possis Medical

Merger to Be Completed Shortly more

31. March 2008

Bayer appeals invalidity ruling on its Yasmin® Patent

Appeal will be heard by the Federal Circuit more

11. February 2008

Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement

Leverkusen, Germany, / Minneapolis, MN, USA – Bayer HealthCare affiliate MEDRAD, Inc., Warrendale, PA and Possis Medical, Inc., Minneapolis, MN, (Nasdaq: POSS), announced today that they have entered... more

28. January 2008

Nexavar® Approved for the Treatment of Kidney Cancer in Japan

First approved oral targeted therapy for metastatic RCC in Japan more

24. January 2008

Bayer extends product portfolio for liver cancer patients in Japan

Japanese authorities grant priority review status for Nexavar® in liver cancer / Launch of liver-specific contrast agent Primovist® in Japan more

23. January 2008

Bayer establishes US special access program for Leukine® while replacing current liquid formulation

Leukine lyophilized formulation temporarily reserved for patients with Acute Myelogenous Leukemia (AML) and those experiencing bone marrow transplantation graft failure or engraftment delay / Bayer... more

17. January 2008

US Food and Drug Administration Approves RECOTHROM™

Leverkusen – Bayer HealthCare announced today that its partner, ZymoGenetics Inc., received US Food and Drug Administration (FDA) approval of RECOTHROM™ Thrombin, topical (recombinant) for use as a... more

9. January 2008

Archer Daniels Midland Company, Bayer CropScience and Daimler to cooperate in Jatropha biodiesel project

A new high-potential biofuel crop more

3. January 2008

Expanded Labeling for MabCampath® in Europe

B-cell chronic lymphocytic leukemia (B-CLL): more

Please enter a searchword.

Copyright © Bayer HealthCare AG